Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A prospective multicenter surveillance program on yeast bloodstream infections was implemented in the Paris, France, area without restrictions on ward of hospitalization (intensive care unit, hematology, and surgery) or age (adults and children). The present analysis concerns 2,618 isolates collected over 7 years from 2,441 patients. Centralized species identification and antifungal susceptibility testing using the EUCAST methodology were performed. Almost 10% (232/2,441) of the patients had recently (≤30 days) been treated with antifungal drugs. We analyzed the effect of recent exposure to fluconazole ( n = 159) or caspofungin ( n = 61) on the proportions of the five major Candida species. For both drugs, preexposure was associated with a decreased prevalence of Candida albicans in favor of less drug-susceptible species ( C. glabrata and C. krusei for the former and C. parapsilosis and, to a lesser extent, C. glabrata and C. krusei for the latter; P = 0.001). In the multivariate analysis, the risk of being infected with an isolate with decreased susceptibility to fluconazole was independently associated with an age of ≥15 years (odds ratio [OR] = 2.45; 95% confidence interval [CI] = 1.39 to 4.31; P = 0.002) and with recent exposure to fluconazole (OR = 2.17; 95% CI = 1.51 to 3.13; P < 0.001), while the risk of being infected with an isolate with decreased susceptibility to caspofungin was independently associated with an age <15 years (OR = 2.53; 95% CI = 1.43 to 4.48; P = 0.001) and with recent exposure to caspofungin (OR = 4.79; 95% CI = 2.47 to 9.28; P < 0.001). These findings could influence future recommendations for the management of candidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, Candida spp. distribution may not vary only between geographical regions, but even between medical centers in close proximity, perhaps affected by factors influencing local epidemiology including prior antifungal exposure and patient age within the ICU.67”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [67]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent exposure to an echinocandin was found to significantly increase the risk of infection with C. parapsilosis [85].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [85]
In the citing paper
“Often, for naturally susceptible species, both the relative amount of resistant strains and the overall MIC levels in clinical isolates increase after the continuous use of a given antifungal drug [44].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [44]
In the citing paper
“Quite soon after the introduction of the echinocandins it was noted that the increasing use was accompanied by epidemiological shifts with a proportional or numeric increase in the less susceptible C. parapsilosis at several centres (8;17;18).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [8]
In the citing paper
“A consequence of enhanced drug exposure is increased selection pressure for resistance and indeed an altered species distribution for invasive infections has been linked to the echinocandin use (8).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 4×
“ysis of susceptibility profiles can occur (30).”
BackgroundResultInfluentialInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 1×
“The 2009 updated guidelines of the Infectious Diseases Society of America (IDSA) recommend that an echinocandin or fluconazole be used as first-line therapy for candidemia before identification of the causative species in nonneutropenic patients (27) and that an echinocandin be used in the case of exposure to fluconaz…”
BackgroundPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“caspofungin or fluconazole, the two major drugs recommended for the first-line treatment of candidemia and for preemptive/ prophylactic treatment in high-risk patients, was associated with changes in the epidemiology of the infection (22, 28).”
BackgroundPosaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Horn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · cited 1×
“In addition, they have been associated with reduced survival in cancer patients with recent azole administration (17, 38, 45).”
BackgroundWingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 2×
“krusei) to fluconazole is observed in hematology populations receiving prolonged fluconazole prophylactically (24, 46) as well as in ICU populations (6, 33).”
BackgroundCandida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 1×
“The relationship between the increased incidence of these species and fluconazole prescription has been debated ever since the introduction of fluconazole as prophylaxis in hematology wards (1, 15, 33, 46) and in ICUs (14).”
Background
Research works printed but not linked: 1
- Timsit, J., H. Dupont, J. Stahl, A. Tabah, O. Lortholary, C. Martin, A. Francais, B. Guidet, and E. Azoulay. 2009. Use of anitfungal therapy in ICU: a prevalent cohort study in 169 ICUs, abstr. M-1033/523. Abstr. 49th Intersci. Conf. Antimicrob. Chemother. American Society for Microbiology, Washington, DC.
Cited by
Items 301–400 of 402
Inhibitory and Anti-Biofilm Effects of Orthoshipon aristatus Against Candida albicans
Rahmasari, R., Chairunissa, A. H., Irianti, M. I., Forestrania, R. C., Arifianti, A. E., Suryadi, H., Makau, J. N., Jantan, I., & Elya, B. (2020) · Pharmaceutical Sciences and Research · doi:10.7454/psr.v7i3.1104 · Cited by 2
Inácio, C. P., Beserra, F. G., Soares, C. R. P., Romaguera, L. M. D., de Araújo, P. S. R., Buonafina, M. D. S., Neto, L. N. D. A., dos Santos, D. C., & Neves, R. P. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14462 · Cited by 2
Insights in Antifungal Drug Discovery
Gay‐Andrieu, F., May, J. P., Li, D., Sun, N., Chen, H., Calderone, R., & Alex, D. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch24 · Cited by 2
Fungal Infections in the Hospitalized Patient
Odom, D. C., & Reno, H. (2015) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2015.03.005 · Cited by 2
Erratum to: An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2014) · Infection · doi:10.1007/s15010-013-0577-x · Cited by 2
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0134 · Cited by 2
Portela, F. V. M. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Alby‐Laurent, F., Chahla, W. A., Brethon, B., Dupont, D., Gandemer, V., Gueguen, G., Lanternier, F., Pasquet, M., Philippe, M., Pluchart, C., et al. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2022.08.004 · Cited by 1
Ezer, B., Uğraklı, S., & Kasapoğlu, E. (2025) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.20880 · Cited by 1
Pawar, K., & Singh, A. K. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002083 · Cited by 1
Lysková, P., Dobiáš, R., Bezdíček, M., Hubka, V., Sumerauerová, P., Lžičařová, D., Kocmanová, I., Buchta, V., Prošková, I., Janouškovcová, H., et al. (2026) · Mycopathologia · doi:10.1007/s11046-026-01076-3 · Cited by 1
Higashijima, K., Kuraoka, T., FUJIMATSU, N., Ambo, A., Ito, F., Ogawa, Y., & Kobayashi, H. (2026) · Microorganisms · doi:10.3390/microorganisms14071472 · Cited by 1
Reizine, F., Henry, J., Desmedt, L., Camus, C., Tadié, J., Coirier, V., Arrivé, F., Burban, E., Eustache, G., Belleville, T., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104178 · Cited by 1
Kiehl, M. G., Egerer, G., Engelhardt, M. M., & Gross, B. N. (2015) · Mycoses · doi:10.1111/myc.12277 · Cited by 1
Antifungal therapy: current concepts and evidence-based management
Perfect, J. R., & Andes, D. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761136 · Cited by 1
The Role of Biomarkers for Starting Antifungals in the Intensive Care Unit
Pagani, J., Revelly, J., Que, Y., & Eggimann, P. (2015) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000118 · Cited by 1
Strategien bei Versagen einer antimykotischen Therapie auf Intensivstation
Arens, C., Bernhard, M., Koch, C., Heininger, A., Störzinger, D., Hoppe‐Tichy, T., Hecker, M., Grabein, B., Weigand, M. A., & Lichtenstern, C. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0072-0 · Cited by 1
Tagliaferri, E., & Menichetti, F. (2014) · Italian Journal of Medicine · doi:10.4081/itjm.2014.536 · Cited by 1
Bagirova, N. S., & Дмитриева, Н. В. (2017) · Laboratory Service · doi:10.17116/labs201763182-189 · Cited by 1
The Triple Threat of the Covid-19 Pandemic- (White, Yellow and Green Fungus)
Raghavendra Rao, M. V., Ali, M., Chennamchetty, V. K., Mathai, D. C., Presilla, T., Verma, Y. K., Vishnu Rao, P., Verma, M. K., & Rao, D. S. (2021) · International Journal of Medical Science · doi:10.14445/23939117/ijms-v8i8p102 · Cited by 1
Acquired knowledge and identified gaps in resistance and human health risk
Nigam, K., & Sanyal, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96124-0.00006-4 · Cited by 1
Grey, A., Joubert, R., Steyn, S. F., & Julyan, M. (2023) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v38i1.470 · Cited by 1
The Prevalence of Candida Species among HIV-Positive Women in Aluu, Nigeria: A Call for Awareness
Cookey, T. I., Ihejirika, M. O., Osuala, O. J., Onu, E. N., Amadi, B. O., Oketah, E. N., Adim, C. C., Innocent-Adiele, H. C., & Okonko, I. O. (2023) · International Journal of Pathogen Research · doi:10.9734/ijpr/2023/v12i6258 · Cited by 1
Meradji, A., Ranque, S., Bachtarzi, F., MOSBAH, N., & Moulahem, T. (2023) · doi:10.3390/ecm2023-16684 · Cited by 1
Leung, R. Y. H., & Lam, J. Y.-W. (2025) · Antibiotics · doi:10.3390/antibiotics14060556 · Cited by 1
Estudio de la resistencia a los antifúngicos en hongos patógenos humanos
Rivero-Menéndez, O. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Mecanismos de resistencia a azoles en especies de candida no-albicans
Navarro-Rodríguez, P. (2019) · Rovira & Virgili repository · Cited by 1
Biological activities of tulbaghia violacea against cryptococcus species
Pattoo, M. (2018) · Nelson Mandela University Research Repository · Cited by 1
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · Wiley eBooks · doi:10.1002/9781683674849.mcm0134 · Cited by 1
da Costa, V. G. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Arboleda Sánchez, H. T. (2019) · Repository Technological University of Pereira (Technological University of Pereira) · Cited by 1
Moret Calvo, A. M. (2017) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 1
Oliveira, V. K. P. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-20032012-163902
De la bonne utilisation des antifongiques systémiques en réanimation
Timsit, J., Potton, L., Lugosi, M., Minet, C., Hamidfar-Roy, R., Ara-Somohano, C., Bonadona, A., & Schwebel, C. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_7
Echinocandins for candidemia: a rational choice
Menichetti, F., & Tagliaferri, E. (2013) · Reviews in Health Care · doi:10.7175/rhc.v4i2s.872
Fongémies et temps d’incubation (TDI) : analyse de 1741 épisodes
Paugam, A., Ancelle, T., Lortholary, O., & Bretagne, S. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.06.016
Self-citationBlennow, O. (2014) · Figshare
Infections fongiques sévères en réanimation
Lerolle, N., Parize, P., & Lortholary, O. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_17
Self-citationAntifungal therapy in the critically ill
Timsit, J., & Azoulay, É. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825ce0c3
Vesicular lesions of the oral mucosa.
Robinson, H. B. (1967) · PubMed
Hundt, A. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12097
Puig‐Asensio, M. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Yeast Infections After Haematopoietic Stem Cell Transplantation
Trubiano, J. A., Chen, S. C.-A., & Slavin, M. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_37
Sun, N. (2013) · DigitalGeorgetown (Georgetown University Library)
Candidemia in hospitalized adults: current challenges and strategies of management
Cuervo, G. (2016) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The impact of lemongrass, oregano, and thyme essential oils on Candida albicans’ virulence factors
Eddins, J. M. (2021) · Access Microbiology · doi:10.1099/acmi.cc2021.po0018
The prescribing practices of echinocandins in adult patients in a private hospital
de Grey, A. D. N. J. (2018) · Boloka Institutional Repository (North-west University)
Prevalence of Candida in Blood Cultures from in patients at a Teaching Hospital in Brazil
de Macedo, V. S. O., Oliveira, S. C. D. S., Rodrigues, M. R. P., Coelho, C. G. V., & Barbosa, F. C. B. (2019) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2019.812.244
Focus sur l’évolution de la résistance des Candida aux antifongiques
Bertholom, C. (2021) · Option/Bio · doi:10.1016/s0992-5945(21)00079-9
Perlin, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_29
(2018) · IJARKE Science & Technology Journal · doi:10.32898/istj.03/1.1article05
Ciências Biológicas e da Saúde: integrando saberes em diferentes contextos - Volume 3
Barbosa Neto, O., Praxedes, M. F. D. S., Silva, P. F. D., & Carvalho Junior, F. F. D. (2023) · Editora Científica Digital eBooks · doi:10.37885/978-65-5360-335-6
Folba, C. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10382
Microbiological Profile of Bloodstream Infections in Cancer Patients
Kabi, S., Swain, B., & Jain, S. (2021) · CHRISMED Journal of Health and Research · doi:10.4103/cjhr.cjhr_11_20
New insights into the echinocandin resistance in Candida spp. in the clinical settingPreprint
Gedeon, A., Kalboussi, Y., Bigot, J., Le, V., Dannaoui, É., Vellaissamy, S., Antignac, M., Petrella, S., Hennequin, C., & Guitard, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591739
Li, S., Liu, J., Zhang, T., Lu, J., Li, M., Zhang, M., & Chen, H. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13633
Hong, S. B. (2024) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2024.30.2.73
Kara, Y., Kızıl, M. C., Nepesov, M. İ., Kaçmaz, E., Kıral, E., Bozan, G., Öz, Y., Kılıç, Ö., & Dinleyici, E. Ç. (2024) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.1422739
Fungal Infection of the Skin –In The Current Scenario
Tayade, R. G., & Wankhede, S. (2024) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-22737
Bohner, F. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12031
Candidemie e candidosi invasive
Benitha, Y., & Bleibtreu, A. (2025) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(24)49999-4
Candidemia y candidiasis invasiva
Benitha, Y., & Bleibtreu, A. (2025) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(25)50394-8
Divine-Anthony, O., Akinmusire, O. O., Bassey, S. S., & Willies, A. P. (2025) · World Journal of Applied Science & Technology · doi:10.4314/wojast.v16i1.29
Schroeder, M. L., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A.-K., Fischer, M., & Kluge, S. (2020) · Figshare · doi:10.6084/m9.figshare.13106465
Schroeder, M. L., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A.-K., Fischer, M., & Kluge, S. (2020) · Figshare · doi:10.6084/m9.figshare.13106456
Schroeder, M. L., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A.-K., Fischer, M., & Kluge, S. (2020) · Figshare · doi:10.6084/m9.figshare.13106462
Schroeder, M. L., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A.-K., Fischer, M., & Kluge, S. (2020) · Figshare · doi:10.6084/m9.figshare.13106453
Use of Membrane Proteins as Antifungal Drug Targets
Lodé, A. (2022) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00045277
Schroeder, M. L., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A.-K., Fischer, M., & Kluge, S. (2020) · Figshare · doi:10.6084/m9.figshare.13106459
Basas Satorras, J., & de Medicina, U. A. D. B. D. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Phan, T. (2019) · UnissResearch (Università degli Studi di Sassari)
FOURNIER, P., & Maubon, D. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
ROSSELLI DEL TURCO, E. (2014) · Electronic Theses and Dissertations Repository (University of Pisa)
Kurland, S. (2024) · Uppsala University Publications (Uppsala University)
Esteban Sanchez, P., Galve Buerba, E. M., & López, A. R. (2018) · Zaguan (Universidad de Zaragoza)
Fernández‐Silva, F. (2013) · Rovira & Virgili repository
Antifungális szerek in vitro és in vivo hatékonyságának a vizsgálata Candida fajok ellen
Majoros, L. (2025) · REAL-d (Hungarian Academy of Sciences)
de Souza, A. C. R. L. A. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Cardona, F., Villetard, F., Zemmour, C., D’Incan, E., Maisano, V., De, M. C. M., Noël, R., Fürst, S., Legrand, F., Mokart, D., et al. (2026) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2026.101605
Wang, F., Yao, Y., Yang, Q., Lin, X., Zheng, Y., Zhou, H., & Huang, Q. (2026) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2025.11.001
Résistance aux antifongiques : détection, mécanismes et épidémiologie
Pasquier, G., & Charif, D. L. (2026) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(26)76541-2
Antifungal stewardship推進を目指した抗真菌薬個別最適化投与法の確立 (本文)
サカモト, ヤ., Sakamoto, Y., & 坂本, 靖. (2021) · Institutional Repositories DataBase (IRDB)
Invasive fungal infections and CARD9 deficiency
Lanternier, F. (2013) · theses.fr (ABES) · doi:10.70675/eae32c8bz836fz4c58z9ce2z34a0ef0a9216
Le granulome à Candida : modèle de persistance pour l’étude de l’interaction hôte-pathogène
Misme‐Aucouturier, B. (2017) · theses.fr (ABES) · doi:10.70675/417f4a06z6c24z44b4z83c1z00d64e72fb36
Developing a novel antifungal strategy by targeting an epigenetic reader domain
Wei, K. (2020) · theses.fr (ABES) · doi:10.70675/ce7dc30ezfb21z43adz8835zf9a2e73daf67
Ali, M., & Al-Ezzy, A. I. A. (2026) · Diyala Journal for Veterinary Sciences · doi:10.71375/djvs.2026.04105
Etude structurale du remodeleur de la chromatine RSC chez Candida albicans
Dupeyron, R. (2023) · theses.fr (ABES) · doi:10.70675/5f7d1879zcfb3z42d7z91e1z9a2a37a29c1f
Katsiari, M., Nikolaou, C., Theodoridou, K., Palla, E., Tsakris, A., & Vrioni, G. (2026) · Pathogens · doi:10.3390/pathogens15070734
Alby‐Laurent, F., Obadia, T., Gits‐Muselli, M., Bougnoux, M., Brethon, B., Mariani‐Kurkdjian, P., Guitard, J., Botterel, F., Chachaty, É., Sitbon, K., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104177
Self-citationChauhan, H., Martolia, J., & Painuly, N. (2025) · International Journal of Environmental Sciences · doi:10.64252/gftkvy30
do Nascimento, C. G. D. S., Giudice, V. M., Borges, J. S., Pereira, P. A., Vieira, E. D. S., da Silva, L. D. P. R., Silva, G. S., Charles, F. C., Ferrão, S. K., Calil, L. N., et al. (2021) · Journal of Innovations in Pharmaceutical and Biological Sciences
Metadata
- Authors
- Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris
- Centre National de la Recherche Scientifique (FR)
- Institut Pasteur (FR)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-02
- Volume
- 55
- Issue
- 2
- Pages
- 532-538
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3028765
- OpenAlex
- W1981025594
- Cited by
- 362
- References
- 47
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 18 · 2021: 18 · 2020: 31 · 2019: 16 · 2018: 34 · 2017: 30 · 2016: 23 · 2015: 31 · 2014: 41 · 2013: 24 · 2012: 26
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Pfizer
- Gilead Sciences
- Astellas Pharma
- Institut Gustave-Roussy
- Institut de Veille Sanitaire
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, caspofungin, fluconazole, Candida species distribution, Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, antifungal susceptibility, reduced susceptibility, fungemia, epidemiology
- MeSH terms
- Caspofungin, Adult, Antifungal Agents, Candida, Candida albicans, Child, Child, Preschool, Cross Infection, France, Humans, Microbial Sensitivity Tests, Paris, Population Surveillance, Prospective Studies, Species Specificity, Fluconazole, Prevalence, Drug Resistance, Fungal, Echinocandins, Lipopeptides, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.